HRMVX | VMVAX | HRMVX / VMVAX | |
Total Expense Ratio | 1.10 | 0.07 | 1,571% |
Annual Report Gross Expense Ratio | 1.15 | 0.07 | 1,643% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | 10.084 | 6.918 | 146% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 50000 | 3000 | 1,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 370M | 31B | 1% |
Annual Yield % from dividends | 0.96 | 2.15 | 45% |
Returns for 1 year | 5.08 | 6.33 | 80% |
Returns for 3 years | 22.16 | 27.39 | 81% |
Returns for 5 years | 70.95 | 66.74 | 106% |
Returns for 10 years | 56.42 | 107.71 | 52% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VTMGX | 18.85 | -0.12 | -0.63% |
Vanguard Developed Markets Index Admiral | |||
SAGCX | 36.41 | -0.23 | -0.63% |
ClearBridge Growth C | |||
CVMCX | 19.42 | -0.13 | -0.66% |
Calvert Emerging Markets Equity C | |||
LICCX | 17.63 | -0.12 | -0.68% |
Lord Abbett International Equity C | |||
PAXGX | 17.69 | -0.23 | -1.28% |
Impax Global Opportunities Investor |